Position in VTRS
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$974,459
+$145,014 QoQ
Shares Held
61,364
-0.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#318
of 1,020 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 37%
Shared 5%
None 58%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Dec 31, 2022CallValue
$311,640
CallShares
28,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $42,596,492 across 20 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
392,480 | $13,297,221 | |
| 2 | ZTS |
Zoetis Inc.
|
116,123 | $8,344,597 | |
| 3 | HLN |
Haleon plc
|
504,080 | $4,703,065 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,217 | $3,368,556 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
51,671 | $3,304,360 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
17,951 | $3,025,461 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
71,842 | $1,151,626 | |
| 8 | VTRS |
Viatris Inc
This page
|
61,364 | $974,459 |
All Filings in VTRS
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $974,459 | 61,364 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $829,445 | 61,395 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $872,967 | 70,118 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $925,343 | 93,469 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $970,404 | 108,668 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $951,348 | 109,225 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,453,001 | 116,707 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $1,498,525 | 129,072 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,823,581 | 265,624 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $3,503,528 | 293,428 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,651,420 | 244,822 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $1,689,697 | 171,369 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,771,797 | 177,535 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $1,909,183 | 198,460 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $2,242,882 | 201,517 | Shares | Defined | 2023-02-17 | |
| 2022-12-31 | $311,640 | 28,000 | Call | Defined | 2023-02-17 | |
| 2022-09-30 | $1,529,150 | 179,478 | Shares | Defined | 2022-10-26 | |
| 2022-09-30 | $238,560 | 28,000 | Call | Defined | 2022-10-26 | |
| 2022-06-30 | $293,160 | 28,000 | Call | Defined | 2022-07-22 | |
| 2022-06-30 | $2,846,571 | 271,879 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $304,640 | 28,000 | Call | Defined | 2022-04-22 | |
| 2022-03-31 | $3,457,238 | 317,761 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $6,587,729 | 486,898 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $378,840 | 28,000 | Call | Defined | 2022-02-14 | |
| 2021-09-30 | $8,428,816 | 622,053 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $9,370,379 | 655,730 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,898,107 | 708,526 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,837,958 | 578,333 | Shares | Defined | 2021-11-19 | |
| No filing history on record for this holder in this stock. | ||||||